LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer

LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) carries a high mortality, and efficacious therapy is lacking. Therapy using chimeric antigen receptor (CAR) T cells has been used efficaciously against hematologic malignancies, but the curative effect against solid tumors is not satisfactory. A lack of antigen tar...

Full description

Bibliographic Details
Main Authors: Ziming Hu, Xiaohu Zheng, Defeng Jiao, Yonggang Zhou, Rui Sun, Baolong Wang, Zhigang Tian, Haiming Wei
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Molecular Therapy: Oncolytics
Subjects:
LunX
CAR-T cell therapy
PDX model
solid tumor
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770520300589

Internet

http://www.sciencedirect.com/science/article/pii/S2372770520300589

Similar Items